2023
DOI: 10.1039/d3tb01441j
|View full text |Cite
|
Sign up to set email alerts
|

Transdermal drug delivery via microneedles for musculoskeletal systems

Abstract: As the population ages and lifestyles change, the prevalence of musculoskeletal (MSK) disorders is gradually increasing with each passing year, posing a serious threat to the health and quality of...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 214 publications
(240 reference statements)
0
4
0
Order By: Relevance
“…Most patients saw decreased edoema within a month and 80% felt better after the first month of treatment. Ayurvedic medication did not cause any toxicity in the liver, kidneys, or anywhere else in the body (Zheng et al, 2023).…”
Section: Discussionmentioning
confidence: 84%
“…Most patients saw decreased edoema within a month and 80% felt better after the first month of treatment. Ayurvedic medication did not cause any toxicity in the liver, kidneys, or anywhere else in the body (Zheng et al, 2023).…”
Section: Discussionmentioning
confidence: 84%
“…According to the metanalysis elaborated by Skinner et al [88], intramuscular testosterone replacement therapy offers a 3-5 times increase in muscle mass and strength than transdermally administered testosterone. One more emerging delivery possibility is using microneedle patches loaded with micronsized needle arrays for non-invasively injecting therapeutic agents to treat musculoskeletal disorders [89]. Nonetheless, further studies dedicated to sarcopenia need to be performed for clarifying the exact outcomes of microneedle patch administration in this disease.…”
Section: Drug Delivery Systemsmentioning
confidence: 99%
“…4 On the other hand, microneedle (MN) patches, which consists of an array of micrometer-sized needles placed on a base support, could help to overcome this problem as it provides fast and painless transdermal drug delivery. 5–7 Moreover, loading 1 week – 12 days requirement of iron in a slow-release biodegradable MN patch would address the issues of bioavailability as well as unpleasant side-effects, at the same time eliminating the need for daily oral supplementary intake, and thus reducing non-compliance risks. There are several iron-containing topical patches available on the market ( e.g.…”
Section: Introductionmentioning
confidence: 99%